When a country's infant mortality rate barely budges over a decade despite near-universal medical attendance at death, the data is telling a story about structural inequality rather than medical capacity. For health researchers, policymakers, and global health advocates, this analysis of over 224,000 infant deaths in Mexico across ten years reveals where systemic gaps persist and what they cost in lives.
Analyzing official mortality microdata from 2014 to 2023, this national study found that Mexico's infant mortality rate held essentially flat at roughly 10.6–10.7 deaths per 1,000 live births. Leading causes were neonatal in origin — respiratory disorders, sepsis, prematurity, and congenital cardiac malformations — consistent with a health burden concentrated in the earliest days of life. Strikingly, nearly 88% of infant deaths occurred among infants without social security affiliation, a proxy for socioeconomic marginalization. Smaller localities showed markedly lower rates of medical attendance and autopsy, alongside higher rates of deaths coded as presumed external causes, suggesting surveillance quality degrades precisely where vulnerability is greatest.
This finding deserves to be read alongside global infant mortality trends: many upper-middle-income countries have achieved meaningful reductions through targeted neonatal intensive care expansion and community health worker programs. Mexico's plateau suggests that aggregate improvements in medical attendance — now at 99.5% — are masking deep territorial and socioeconomic stratification. A near-perfect attendance metric coexisting with persistent mortality signals a quality-of-care and access-to-specialist-services problem, not merely a coverage problem. The reliance on social security affiliation as a de facto health tier is a well-documented structural vulnerability in Latin American systems, but the magnitude here — 88% — is a sharp quantification. Key limitations include the observational, administrative-data design, which cannot establish causal pathways or capture care quality. Still, the decade-long scope and national sample make this a methodologically robust baseline for targeted neonatal equity interventions.